Antidepressants Flashcards

(41 cards)

1
Q

First line antidepressants

A

SSRI
SNRI
Bupropion
Mirtazapine
Vortioxetine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Adequate trial of antidepressant

A

4-8 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Remission definition

A

3 weeks with no symptoms of depressed mood & anhedonia, and no more than 3 remaining symptoms of depression

Remission = goal of therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Onset of effectiveness

A

2-4 weeks: improvement in physical symptoms (energy, sleep)

-If partial response at 4 weeks, need longer trial

4-6 weeks: full effect

8 weeks: response

12 weeks: remission

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Maintenance of therapy

A

Once reached remission (at least 12 weeks!) continue for another 6-9 months

If risk factor for recurrent depression, treat for 2 years or longer
(frequent recurrent episodes, severe episodes, chronic episodes, presence of comorbid psych condition, residual symptoms)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

1A2 sub, inhib, inducer

A

Substrate:
Duloxetine

Inducer:
Cannabis, tobacco

Inhibitor:
Caffeine, fluvoxamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

2C19 sub, inducer, inhib

A

Substrate:
Citalopram
Escitalopram
Fluoextine
Imipramine
Viladozone

Inducer:
St Johns wort

Inhibitor
Amitriptyline
Cannabis
Fluoxetine
Fluvoxamine
Imipramine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

2D6 sub, inhibitor

A

Substrate:
Amitriptyline
Desipramine
Duloxetine
Fluoxetine
Imipramine
Nefazodone
Nortriptyline
Trazodone
Venlafaxine
Vortioxetine

Inhibitor
Bupropion
Cannabis
Duloxetine
Fluoxetine
Paroxetine
Sertraline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

3A4 sub, inducer, inhib

A

Substrate
Citalopram
Escitalopram
Levomilnacipran
Nefazodone
Trazodone
Venlafaxine
Vilazodone

Inducer
St Johns wort

Inhib
Fluvoxamine
Nefazodone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

SSRI with longest half life

A

fluoxetine (1-4 days)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Most activating SSRIs

A

Fluoxetine
Sertraline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Most sedating SSRIs

A

Paroxetine
Fluvoxamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Most common ADR of SSRI

A

GI upset
Insomnia
Restlessness
Headache
Sexual dysfunction (>=50% of ppl)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Intervention for SSRI induced sexual dysfunction

A
  1. Wait and see
  2. Add bupropion
  3. Lower SSRI dose
  4. Add PDE-5 inhibitor in men
  5. Weak data, but add buspirone or mirtazapine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Serotonin syndrome

A

3 clusters of symptoms:
-Neuromuscular hyperactivity (myoconlus, rigidity, tremors)
-Altered Mental Status (agitation, confusion, hypomania)
-Autonomic instability (hyperthermia, diaphoresis)

Hunter criteria used to identify

Treatment:
1. D/C offending agent
2. Supportive measures
3 Give cyproheptadine; a benzo for myoclonus; antiseizure meds; nifedipine for HTN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Other serotonergic meds to increase risk of serotonin syndrome

A

MAOIs
Dextromethorphan
Meperidine
Tramadol
Sympathomimetics
Linezolid
Lithium
TCAs
SNRIs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Withdrawal of SSRI

A

Flu-like symptoms (nausea, chills)
Neurologic symptoms (paresthesias, insomnia, anxiety, electric shock sensations)

Gradual dose reduction needed even for long half life

18
Q

Citalopram ADR

A

QTc prolongation, especially doses > 40mg

FDA now limits daily dose to <= 40mg

20mg max if hepatic impairment, >60, 2C19 poor metabolizer, or 2C19 inhibitor

19
Q

Renal adjustment needed for these SNRIs

A

Desvenlafaxine
Levomilnacipran

Avoid duloxetine in severe renal impairment

20
Q

SNRI for hepatic insufficency

A

Desvenlafaxine - bypasses CYP metabolism

21
Q

SNRIs and hypertension

A

Usually mild and not clinically significant UNLESS uncontrolled HTN

22
Q

SNRI with orthostatic hypotension

A

Levomilnacipran
Desvenlafaxine

23
Q

Vilazodone (viibryd) CI

A

History of seizure

24
Q

Vortioxetine (trintellex) unique MOA

A

SSRI +
-serotonin 1A agonist
-serotonin 1B partial agonist
-serotonin 3 antagonist
-serotonin-1D antagonist
-serotonin-7 antagonist

Improves cognitive function

Lower risk of sexual dysfunction

25
Trazodone unique ADR
Priapism (medical emergency)
26
Nefazodone BBW
Liver toxicity Must monitor LFTs 2-3rd line agent
27
Mirtazapine sedative effect, other ADRs
Sedating at lower doses Insomnia at higher doses weight gain (inc. appetite), constipation, asthenia
28
Bupropion unique ADR
Increased risk of seizures
29
Bupropion seizure risk management
1. Avoid use in all susceptible patients 2. Do not give >150mg/dose or >450mg/day 3. Avoid dose titrations more often than every 4 days (XR, SR) or 3 days (IR)
30
Bupropion + Dextromethorphan
Combination for treatment of depression
31
Tertiary amine TCAs
Amitriptyline Imipramine More potent for serotonergic reuptake inhibition
32
Secondary amine TCAs
Nortriptyline Desipramine More selective for norepinephrine reuptake inhibition Less anticholinergic
33
TCA in overdose
Cardiotoxic - causing prolonged QTc and TdP, seizures Do not give to actively suicidal patient
34
TCA ADRs
Anticholinergic (amitriptyline) Sedation (amitriptyline) Orthostatic hypotension (imipramine) Cardiotoxic (amitriptyline & imipramine)
35
Avoid TCAs in these populations
Cardiac disease Seizure disorder Actively suicidal
36
Nonselective MAOIs
Isocarboxazid Phenelzine Tranylcypromine
37
MAOIs + tyramine
Potential for hypertensive crisis Avoid aged cheese, preserved meats, wine, beer
38
Gepirone
New antidepressant Take with food QTc prolongation No sexual dysfunction side effect
39
Antidepressants and suicidality
ALL carry BBW for increased risk of suicide in children, adolescents, young adults up to 24. Highest risk at initiation or dose adjustment -- since physical symptoms improve first, more energy to act out. Do not avoid treatment due to risk of suicide
40
SGA with FDA approval for adjust to antidepressants
Aripiprazole Brexpiprazole Cariprazine Quetiapine ER Almost all used
41
Treatment resistant depression
1. Olanazpine + fluoxetine 2. Esketamine (onset within hours)